Read More Pharma Industry News Novartis’ atrasentan shows significant reduction in proteinuria in seasonal allergic rhinitis patients Novartis presented compelling interim results from the Phase III ALIGN study evaluating the efficacy of atrasentan, an investigational… byPallavi MadhirajuMay 25, 2024